Synmosa Biopharma Corporation (TPEX: 4114)
Taiwan
· Delayed Price · Currency is TWD 33.30
-0.15 (-0.45%)
Dec 20, 2024, 1:30 PM CST
Synmosa Biopharma Market Cap
Synmosa Biopharma has a market cap or net worth of 13.99 billion as of December 20, 2024. Its market cap has decreased by -2.70% in one year.
Market Cap
13.99B
Enterprise Value
16.05B
Revenue
5.38B
Ranking
n/a
PE Ratio
19.49
Stock Price
33.30
Market Cap Chart
Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 13.99B, an increase of 2,298.44%. That is a compound annual growth rate of 18.59%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition